Table 4.
Histological risk factors of the patients and the adjuvant therapy received (no. of surgery = 72).
| Variable | n(%) | Median (range) |
|---|---|---|
| Tumor size, mm | 25(0–40) | |
| Pelvic lymph nodes | 18(10–31) | |
| Para-aortic lymph nodes | 6(4–18) | |
| Lymph node positivity, n(%) | 13(18.1%) | |
| Lymphovascular space invasion, n(%) | 13(18.0%) | |
| Deep stromal invasion, n(%) | 37(51.4%) | |
| Parametrial width, cm | 2(1–4) | |
| Positive parametrial margins, n(%) | 1(1.4%) | |
| Positive vaginal margins, n(%) | 0(0%) | |
| Adjuvant treatment, n(%) | ||
| Radiotherapy | 11(15.2%) | |
| Concurrent chemoradiotherapy | 28(38.8%) | |
| Chemotherapy | 3(4.1%) | |
| Recurrence, n(%) | 5(6.9%) | |
| Site of recurrencea, n(%) | ||
| Local | 1(1.4%) | |
| Regional | 2(2.8) | |
| Distant | 3(4.1%) | |
| Death of disease, n(%) | 1(1.4%) | |
SPSS 17.0 (IBM Corp, Armonk, NY, USA) was used for statistical analysis.The website of SPSS is https://www.ibm.com/cn-zh/analytics/spss-statistics-software.
aOne patient had multiple sites of recurrence.